The fatty liver dystrophy (fld) mutation is an autosomal recessive mutation that occurred spontaneously in the BALBkByJ mouse strain in 198 1 (1) . The mutant phenotype is characterized by fatty liver and hypertriglyceridemia during neonatal development, and by a peripheral neuropathy which progresses throughout the lifetime of the animal (2,3). Also associated with the fld phenotype during the neonatal period are tissue-specific alterations in expression of several proteins involved in lipoprotein metabolism. For example, lipoprotein lipase (LPL) 1 in white adipose tissue is reduced to 6% of normal activity, although LPL activity is reduced by only 50% in brown adipose and heart. In addition, hepatic lipase activity in the circulation is reduced to 20% of normal levels, whereas mPJIA levels for apolipoproteins A-IV and CII are significantly elevated in liver (100-fold and 6-fold, respectively), yet appear normal in intestine (2).
Interestingly, the fatty liver and the abnormalities in triglyceride metabolism, lipase and apolipoprotein expression in fld/fld pups spontaneously resolve during the suckling/weaning transition (postnatal days 13-15) (2). Although this reversion coincides with the change from a diet that is rich in triglycerides (mother's milk) to a diet that is low in fat and high in carbohydrates (laboratory chow), the resolution appears to be effected by a genetically programmed event and not the result of a change in diet. Thus, in fldfld mice in which weaning has been delayed, the triglyceride levels, as well as apo A-IV mRNA and apo C-II mRNA levels, return to normal on the same schedule as in weaned mice (2). In addition, the lipid abnormalities evident in neonatal fld/fld mice cannot be elicited by feeding adult animals a high fat diet rich in triglycerides (2) . These results suggest that the mutation at the fld locus disrupts the normal expression or activity of proteins required for lipid homeostasis during the neonatal period.
The peripheral neuropathy, which is manifested in an unsteady gait shortly before weaning and progresses throughout the lifetime of fldfld mice, may also be associated with a defect in lipid metabolism. Sciatic nerve fibers from fld/fld adult mice exhibit deficiencies in phospholipids, glycosphingolipids, and neutral lipids, and elevated cholesterol esters (3) . In contdast, no differences J / are evident in the composition of brain lipids between fld/fld mice and their unaffected littermates suggesting that the mutation affects peripheral but not centrd nerve tissue. The morphology of sciatic nerve in mutant mice revealed a variety of gross abnormalities in myelin structure including thin, poorly compacted myelin sheaths, ongoing myelin breakdown, and enlarged Schwann cell mitochondria and nuclei (3). Coincident with these morphologic changes, altered levels of peripheral nerve myelin-and axon-specific proteins also exist. Taken together, the varied aspects of the fld mutant phenotype indicate that the fld mouse is an excellent model in which to investigate potentially related mechanisms controlling lipid metabolism in newborn mice and those contributing to the development and maintenance of peripheral nerve.
In this report we further characterize the metabolic deficiencies contributing to the fatty liver in fldfld mice during the neonatal period. During the fatty liver stage, triglyceride droplets accumulate within hepatocytes .of fldfld mice. This phenotype, together with elevated apo A-IV mRNA and reduced hepatic lipase activity, persists in hepatocytes isolated from neonatal mice and maintained in culture. We have examined several aspects of hepatic triglyceride metabolism in fld/fld mice and determined that neonatal fld/fld hepatocytes do not exhibit a consitutive increase in triglyceride synthesis, but rather accumulate fatty acids. Furthermore, the rate of fatty acid oxidation in cultured neonatal fld/fld hepatocytes is significantly reduced compared to wild-type cells. Only a single other mouse mutation has been described which affects fatty acid oxidation; co-incidentally, that mutation occuFd in the same mouse strain as the fld mutation. Using a definitive PCR assay, we determined that the fld mutation is distinct from the previously described mutation and represents a second mouse model with a defect in fatty acid oxidation. Finally, using quantitative two-dimensional electrophoresis, we demonstrate that, in addition to lipases and apolipoproteins, expression levels of at least 25 proteins are significantly altered in the €ld/fld neonatal liver. The identification of these proteins may lead to a better understanding of normal cellular triglyceride metabolism in neonatal liver and reveal candidates for the fld gene product. Primary hepatocyte isolation-Hepatocytes were isolated by recirculating perfusion of livers from 10-12 day old and adult mice as described (4). Perfusion of the livers from young mice was made possible by the use of extra fine tubing (0.5 mm diameter) for cannulation of the portal vein (BioTime, Inc., Berkeley, CA). Primary hepatocytes were cultured in arginine-free DMEM containing 10% fetal calf serum at 37OC in 5% C02. The use of arginine-free medium prevents the growth of fibroblasts which may be present in hepatocyte preparations from neonatal mice.
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METHODS
Animals
RNA Analysis-Total RNA was prepared from heptaocytes using T r i z o P (Gibco-BRL). RNA (10 pg) was electrophoresed in formaldehyde gels, blotted, and hybridized with cDNA probes for mouse apo A-IV and apo A-I as described (5) .
In vivo metabolism of [3H]oleic acid-[9,10(n)-3H]oleic acid (10.0 Ci/mmol, Amersham) was evaporated in a glass tube and resuspended in NaOH at a molar ratio of 1 :4 (oleate-NaOH). 50 pCi of saponified oleate was dissolved in 3Opl (for 3 day old mice) or 100 p1 (for adult mice) of PBS and injected I.P. Initial trials were also performed by direct perfusion of liver which had been cannulated through the portal vein and excised. After a 15 min pulse, mice were killed (or perfusion stopped) and livers collected. Livers were homogenized in buffer containing 0.25 M sucrose, 20 mM Tris-HCl, pH 7.4,l mM EDTA, and 1 mM DTT.
Lipid analyses-Lipids were prepared from liver homogenates by extraction with chloroform and methanol (6). Phospholipid concentration was estimated by quantitation of phosphorus (7) . Neutral lipids were separated by thin-layer chromatography on high performance silica gel plates (Aldrich Chemical Co.) in hexane-diethyl ether-acetic acid (80:ZO: l), and visualized by charring in 3% cupric acetate/8 % phosphoric acid or by incorporation of iodine vapor (7) . Radioactivity of neutral lipid species from oleate labeling experiments were determined by scintillation counting of silica gel spots in EcoLite (ICN). For quantitation of radiolabeled phospholipid, silica gel spots were incubated for 5 min.
in 0.1 ml of 0.1 M KOH in ethanol at 37OC and neutralized with 10 pl acetic acid before addition of scintillation cocktail.
Plasma free fatty acid levels were determined enzymatically using reagents from Wako Chemical Primary skin fibroblast culture-Primary fibroblast cultures were established from skin explants of 10 day old fldfld and wild-type mice. Skin samples 1 cm square were placed into 30 mm pertri dishes in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 100 units/ml penicillin, 100 p g l d streptomycin, and incubated at 37OC in 5% C02. After a few days, fibroblasts migrating out from the explants were removed from the dish by treatment with trypsin and passaged to fresh dishes. Fibroblasts were used in oxidation experiments between passages 3-5.
Triacylglycerol lipase assays -Hepatic lipase activity in plasma and hepatocyte culture medium was determined utilizing a tri[3H]oleate substrate (9) . Assays were performed in duplicate with 2 pi plasma from 3-4 mice of each type, or wiih 50 PI culture medium from 2-4 culture plates after incubation with 10 Ulml heparin for 24 hours. Liver samples used for acid lipase activity determinations were prepared as 20% (w/v) homogenates in 0. 15 abolish cellular metabolism. In initial studies, cells were incubated in the palmitate reaction mixture for times ranging from .i5 min to 3 h to ascertain linearity of the assay. For data presented, 2 hr were employed, at which time the reaction medium was collected from the cell monolayers and treated with 0.2 ml 10% trichloroacetic acid. Cell monolayers were washed with an additional 0.1 ml PBS and the wash pooled with the initial reaction medium. The protein precipitate was removed by centrifugation at 8500 g for 5 min. Supernatants were treated with 70 pl of 6 N NaOH, and applied to a 1 ml Dowex-1 (Sigma Chemical) column. The 3H20, which is an end product of oxidation, passes through the column. This sample, together with a 1 ml water wash, was directly quantitated by scintillation counting in 10 ml EcoLite (ICN, b i n e , CA).
To detennine total cellular protein of cultures used for oxidation assays, 1 ml cf water was added to cell monolayers after removal of reaction medium and cells were subjected to 3 cycles of freezing (-7WC) and thawing (37OC). Proteins were determined using a modified Bradford protein assay reagent (BioRad, Richmond, CA).
Polymerase chain reaction-The polymerase chain reaction (PCR) was used to distinguish wild-type and mutant alleles for the butyryl-CoA dehydrogenase (bcd) gene in BALBlcByJ-fld mice and mice of additional BALBk sublines. Genomic DNA was isolated from the tail of both 10 day old and add t fldfld and unaffected mice using proteinase K digestion followed by phenoVchloroform extractions and ethanol precipitation (1 1). Genomic DNA from control strains BALBkJ, BALBkBy, , .
. ,. k and BALB/cByJ was purchased from the Jackson Laboratoq (Bar Harbor, ME). The PCR was performed using primers that flank a deletion occumng in the bcd mutant allele (5' primer, 5'-TGGCGTGCTWCATGTI'GA-3'; 3' primer, 5'-CCTTGTGTKITWCTCCGA-3') (adapted from reference 12). Each reaction contained 1 pg genomic DNA, 15 pmol each primer, 50 mM KCl, 10 mh4 Tis, pH 8.8,2.5 mM MgCl2,200 ph4 each deoxyribonucleoside triphosphate, 0.1% Triton X-100, and 2 U Taq polymerase (Perkin-Elmer/Cetus). The amplification was performed for 30 cycles of 1 min 95OC, 1 m h 57OC, and 1 min 72OC. F'rdicts were analyzed on a 2% NuSieve agarose gels (FMC Bioproducts, Rockland, ME).
Quantitative Zdixnensional gel electrophoresis-Livers were harvested from 5-7 day old fldfld and wild-type mice and immediately frozen in liquid nitrogen until processing. In preparation for electrophoresis, livers were homogenized in 1 ml of a solution containing 9M urea, 4% Nonidet P-QO, 5% B-mercaptoethanol and 2% pH 9-1 1 ampholytes per 250 mg (frozen tissue weight) (13). The homogenate was centrifuged for 5 min at 100,OOO rprn (435,000 x g) in a Beckman TL 100 ultracentrifuge, and the supernatant decanted. In addition to triglyceride accumulation, hepatocytes isolated from neonatal fldfld mice and cultured in vitro exhibit dramatically elevated levels of apo A-IV mRNA. As shown in Fig. 3 , apo A-IV mRNA is nearly undetectable in hepatocytes isolated from 10 day old wild-type mice, but is greatly (Fig. 4) .
We next investigated whether the accumulation of triglyceride in the fatty liver is due to increased constitutive triglyceride synthesis. The livers of fld/fld mice appear normal at birth, but become completely fatty within the first 24 hours of suckling. Since acid lipase hydrolytic activity appears normal in the fatty liver, it is likely that increased triglyceride synthesis occurs during the first 11 mutation, it should occur throughout the fatty liver stage. To address this possibility we examined the rate of fatty acid incorporation into triglyceride and other lipids in 3 day old mice in which the fatty liver has been fully established. Due to the small size of neonatal mice, we found it necessary to administer the label by intraperitoneal injection rather than by intravenous injection or direct perfusion of the liver.
To confirm that I.P. injection gives representative results, we performed pilot studies in addt mice to compare the incorporation of radiolabeled-oleic acid into hepatic lipids when administered via direct perfusion of the hepatic portal vein or by I.P. injection. After a 15 minute pulse, the incorporation of label into specific hepatic lipid species was determined by separating neutral lipids using thin layer chromatography followed by scintillation counting of specific lipid species. The proportion of label incorporated into various lipid species (triacylglycerol, diacylglycerol, cholesteryl ester, phospholipid, and free fatty acid) was identical for perfusion and I.P. injection, although the labeling efficiency was several-fold higher for perfusion (data not shown). These results indicate that LP. injection gives an accurate representation of the relative incorporation into lipid species and is a suitable method tu use with neonatal mice which are too small for perfusion.
Results of oleic acid labeling studies performed with 3 day old fldlfld and wild-type mice are shown in Fig. 5a . The proportion of label incorporated into triacylglycerol, diacylglycerol, and cholesteryl ester fractions was similar between fldfld and wild-type mice. However, the fldfld mice exhibited 2.5 fold higher levels of free oleic acid (significant at p>O.Ol), and a 25% lower incorporation of labelled oleate into phospholipids (not significant). Similar studies performed in adult mice in which the fatty liver has resolved revealed that the proportion of label occunng as free fatty acid in the fldfld liver is reduced, and phospholipid incorporation increased, to wild-type levels (Fig. 5b) . These results indicate that the maintenance of the fatty liver in fld/fld neonates is associated with increased levels of free fatty acid and not with increased triglyceride synthesis from fatty acid precursor. We also detected an age-dependent elevation of free fatty acid levels in the blood of fldfld mice, with approximately 40% higher levels in 5 day old fldfld mice, diminishing to normal levels by 1 month of age (Fig 5c) The elevated levels of free fatty acid in fld/fld liver and blood are consistent with a defect in fatty acid metabolism. A characteristic finding in human subjects with genetic defects in fatty acid oxidation is the Occurence of hypoglycemia during fasting and acute episodes (17). Plasma glucose levels in pooled samples of 8 day old fldfld and wild-type mice (4 mice/pool) were 67 mg/dl and 151 rng/dl, respectively. The Occurrance of hypoglycemia together with elevated fatty acid levels in fldfld neonates lead us to investigate whether there is a fatty acid oxidation deficiency in the fldfld liver. For these studies we employed a radiolabekd fatty acid substrate ![9,1O(n)-3H-palmitate]) that allows detection of medium and long chain fatty acid 8-oxidation disorders (1 8) . Primary hepatocytes, cultured overnight, were incubated with this substrate for 2 hours, and the release of 3H2O quantitated as a measure of the rate of P-oxidation (10).
Results of *e palmitate oxidation assay are shown in Table I . In assays performed with neonatal hepatocytes, fldfld cells consistently exhibited a 60% reduction in the rate of palmitate oxidation compared to cells from wild-type mice. To ascertain whether reduced fatty acid oxidation is evident in other neonatal cell types which do not accumulate lipid, the fatty acid oxidation assay was performed in skin fibroblasts isolated from 10 day old fld/fld and unaffected mice. Impaired oxidation was evident in neonatal fibroblasts, but was less severe than in neonatal hepatocytes, with a 39% reduction in fld/fld compared to unaffected mouse cells (Table 1) . We also used the palmitate oxidation assay to determine oxidation efficiency in hepatocytes from young adult mice (60 days old) that no longer accumulate intracellular triglyceride. In contrast to the phenotype seen with neonatal hepatocytes, cells from adult fld/fld and wild-type mice showed similar rates of oxidation (Table 1) . Thus, fatty acid oxidation is impaired in neonatal but not adult fldfld hepatocytes. These results parallel those described above indicating that free fatty acid levels are elevated in both liver and plasma of neonatal fldfld mice, but return to normal in the adult animals. Taken together, the findings suggest that impaired fatty acid oxidation during neonatal development contributes to the formation and/or maintenance of the fatty liver. To determine whether the fld mice carry the mutant bcd allele, we used a PCR assay to distinguish between the native and mutant bcd-1 genes (12). This assay employs oligonucleotide primers that flank the deletion occumng in the mutant bcd gene so that PCR products of different sizes x e produced for the cative compared to the mutant allele. As shown in Fig. 6 , using DNA from BALB/cJ and BALBlcBy, only the native PCR product of 870 bp is produced; in contrast, DNA from the BALB/cByJ strain produces a 592 bp product due to a 278 bp deletion in the mutant allele.
BALBkByJ-fldfld
Interestingly, DNA from BALBlcByJ-fld mice exhibiting both the wild-type and the fld phenotypes produce amplification products characteristic of the native bcd allele. This indicates that the BALBkByJ-fld strain does not carry an underlying butyryl CoA dehydrogenase deficiency, and that the fld defect represents a distinct mutation associated with impaired fatty acid oxidation. Furthermore, these data demonstrate that the bcd mutation must have occured in the BALB/cByJ parental strain recently, sometime after the BALBkByJ-fld breeding stock was isolated in about 198 1 (1) . (2) revealed altered expression levels of four proteins involved in lipid metabolism-hepatic lipase, lipoprotein lipase, apo A-IV, and apo C-II. In addition, in the current study we have presented biochemical evidence for alterea activity of one or more proteins involved in fatty acid oxidation. To produce an overview of protein expression alterations in the fld fatty liver, we performed quantitative 2-dimensiorial gel electrophoresis (2DE) of total proteins in livers from 5 day old fldfld and wild-type mice. Equivalent amounts of protein from liver homogenates were subjected to isoelectric focusing followed by electrophoresis in 9-17% SDS polyacrylamide slab gels, and protein patterns were analyzed (" . .
iy Liver samples from each of ten wild-type and ten 4 &,
%
fldfld mice were examined; a typical 2DE pattern from an fldfld liver is shown in Fig. 7 . Homogenates from fldfld and wild-type livers produced qualitatively similar 2DE patterns; however, quantitation of more than 400 distinct proteins detected by Coomassie Blue staining revealed significantly altered levels (a<O.OOl) of 25 proteins in mutant compared to wild-type mice (arrows in Fig. 7 and Table 2 ). Of these, 23 proteins were expressed at significantly higher levels in fldfld liver, whereas only 2 proteins (spots 36 and 112) were diminished in the mutant mice ( Table 2) . Interestingly, protein spot 112 was undetectable in 5 of the 10 fldfld liver samples analyzed, and in the remaining fldfld samples its level was reduced by 50%.
A comparison of the 2DE patterns with the mouse protein database maintained at Argonne National Laboratory (13) allowed identification of some of the 25 differentially expressed proteins.
Proteins with elevated expression levels in fld/fld liver include keratin (spot 23), f3-actin (spot 29), and yactin (spot 185). Additionally, spot 245 and 206 were identified as apo A-IV and apo E, respectively, by immunoblot analysis using specific antibodies (data not shown). Thus, in agreement with the previously detected elevations in mRNA for apo A-lV and apo E (2), apo A-IV protein levels are elevated 7-fold and apo E levels elevated 2.6-fold in the fatty liver of fld/fld mice. Expression levels of a related protein, apo A-I (spot 294 in the mouse protein database), are not altered in fldfld liver, in agreement with our mRNA measurements (see Fig. 3 ). The database also provides information about the relative abundance of proteins in three subcellular compartments (cytosol, mitochondria, and microsomes). The two proteins with diminished levels in fld/fld liver (36 and 112), as well as several of the proteins elevated in fld/fld, are most abundant in the cytosolic fraction ( Table 2 ). The mouse prokin database also contains information about the quantitative response of proteins to four different chemicals known to produce peroxisome proliferation in the liver (clofibrate, cipofibrate, di-(2-ethylhexyl)-phthalate, and WY-14,463). Of the 17 proteins which show altered expression in fldfld liver and for which data are available, 88% (15/17) respond to at least one of the four peroxisome proliferating agents, the majority of which (65%; 11/17) respond to one specific proliferating chemical, WY-14,463. To identify the metabolic defect that leads to formation of the fatty liver, we investigated several aspects of cellular triglyceride metabolism. We first measured the activity of acid triacylglycerol lipase, an enzyme responsible for hydrolysis of dietary triglycerides entering the liver from lipoprotein remnants in the blood (16). Normal acid lipase activity was detected in liver extracts from fldfld mice of all ages indicating that triglyceride accumulation does not result from a defect in hydrolysis of exogenous triglyceride. A second possible mechanism for triglyceride accumulation is increased triglyceride synthesis in fldfld hepatocytes. Since the livers of fldfld mice appear normal at birth, but are completely fatty and hypertrophied after suckling for a day, it is likely that increased triglyceride synthesis does occur during the initial 24 hours. However, our metabolic labeling experiments performed in 3 day old mice revealed that increased triglyceride synthesis is not required for maintenance of the fatty liver throughout the neonatal period. Rather than increased rates of fatty acid incorporation into triglyceride, we observed an accumulation of free fatty acid in the liver (see Figs. 2 and 5a). Furthermore, plasma free fatty acid levels were elevated in fld/fld neonates, with levels highest in very young mice and returning to normal by the age of one month. These results indicate that increased triglyceride synthesis is not the underlying defect responsible for the fatty liver, and suggested that a defect in fatty acid oxidation may be involved.
The direct quantitation of fatty acid oxidation in neonatal fldfld hepatocytes revealed a 60% decrease in the rate of palmitate oxidation. Similar studies performed in fibroblasts also showed a reduced efficiency (40%), although less pronounced than in hepatocytes. The lack of lipid accumulation in fldfld fibroblasts even thcugh they exhibit impaired fatty acid oxidation is presumably due to the fact that this cell type does not take up triglyceride-rich lipoproteins from the blood, and is consistent with what has been observed in fibroblasts derived from human patients with inborn errors in fatty acid oxidation (17). Interestingly, the fatty liver phenotype closely resembles that of suckling rats which have been treated with fatty acid oxidation inhibitors. Administration of a single dose of a carnitine acyl transferase inhibitor to suckling rats results in fatty liver formation within 18 hours (23). However, treatment of adult rat liver with the same inhibitor results in stimulation of hepatic very low density lipoprotein (VLDL) secretion (24). This difference between neonatal and adult response has been attributed to the fact that the neonatal rodent liver has a limited capacity to secrete VLDL triglyceride (15) . Thus, results from our study are consistent with the hypothesis that the fatty liver in fld/fld neonates results from impaired fatty acid oxidation compounded by both high levels of dietary triglyceride derived from mother's milk, and the inability to secrete VLDL. The spontaneous resolution of the fatty liver at the age of weaning corresponds temporally to both a reduction in dietary fat and acquisition of the capacity for VLDL secretion. However, as Langner et al. (2) have previously demonstrated, neither prolonged suckling of fldfld pups beyond the normal age of weaning nor feeding adult fldfld mice a triglyceride-rich diet elicit fatty liver formation. Based on these observations, it seems likely that the initiation of VLDL secretion at a particular developmental stage is a major factor contributing to the resolution of the fatty liver. acid oxidation in hepatocytes from adult fld/fld mice. It is clear that adult fld/fld mice exhibit none of the secondary pheontypes associated with impaired fatty acid oxidation, such as increased fatty acid levels in blood or liver. In adult mice the consumption of a low fat diet together with the capacity for VLDL secretion may not require that fatty acid oxidation be operating at full capacity. In that case, adult hepatocytes that are isolated and subjected to the oxidation assay may be capable of oxidizing the radiolabeled substrate at high efficiency for the 1 hour duration of the assay before the oxidation pathway becomes cverburdened. Another possibility is that the capacity for fatty acid oxidation in adult liver is different than in neonatal liver due to developmentally programmed alterations in the expression of fatty acid oxidation enzymes. For example, levels of the acyl-CoA dehydrogenases, enzymes that catalyze the first step of mitochondrial fatty acid oxidation, are low at birth, increase several-fold to'peak at postnatal days 10-14, and then diminish to birth IeveIs (25). Thus, these enzymes are critical for maintaining lipid homeostasis during the neonatal period corresponding to the fatty liver stage, and then abruptly decline as the requirement for oxidation of diet derived fatty acids declines when animals are weaned to a low fat diet (days 14-17). Thus, if the fld mutation affects a protein, such as an acyl CoA dehydrogenase, whose expression is most important during the neonatal period, a phenomenon similar that that seen with the fld fatty liver might occur. Alternatively, expression of proteins with functions that may compensate for that of the mutant protein could be switched on at the time corresponding to resolution of the fatty liver. Furthermore, the results demonstrate that a deficiency in the bcd allele does not contribute to the fld phenotype, and that the fld defect represents a second mouse mutation leading to impaired fatty acid oxidation.
Some aspects of the neonatal fld/fld mouse phenotype resemble disorders in mitochondrial or peroxisomal fatty acid oxidation that occur in humans. The B-oxidation of fatty acids occurs in both mitachondria and peroxisomes via independent and distinct enzyme systems (reviewed in 26,27,28) .
The two organelles also differ in their substrate specificities, with mitochondria serving as the primary site for oxidation of short-(C4-C6), medium-(C8-16) and long-chain (C18-22) fatty acids, whereas peroxisomes catalyze the oxidation of very long-chain (C24-26) fatty acids, dicarboxylic acids, branched chain fatty acids, and prostaglandins. Some general characteristics of human mitochondrial fatty acid oxidation disorders that are also apparent in fld./fld mice include fatty liver, hypoglycemia, increased free fatty acid concentration in serum, and reduced fatty acid oxidation in fibroblasts. Furthermore, the degree to which fatty acid oxidation is impaired in fld/fld fibroblasts (38%) is similar to that reported for some human fatty acid oxidation disorders using the same assay conditions employed here. For example, human disorders that may each exhibit reductions of 40-85% in oxidation activity include medium-chain acyl CoA dehydrogenase deficiency, long-chain acyl CoA dehydrogenase deficiency, and deficiencies (mild form) in electron transfer flavoprotein and electron transfer flavoprotein dehydrogenase (18). These disorders in mitochondrial oxidation are characterized by the accumulation of specific metabolic intermediates. For example, deficiencies in medium-chain and long-chain acyl CoA dehydrogenases, and electron transfer flavoprotein, are typified by the accumulation of dicarboxylic (adipic, suberic, and sebacic) acids (17,29). A preliminary examination of the organic acids present in livers of fldfld neonates via mass spectrometry/gas chromatography has revealed normal levels of dicarboxylic acids (K. Reue and L. Sweetman, unpublished observations). In this respect the fatty acid oxidation disorder in the fld mouse appears not to mirror the human disorders in mitochondrial fatty acid oxidation mentioned above. However, it should be noted that differences exist between mice and humans in the efficiency with which fatty acid metabolites are eliminated, and this could produce different biochemical and pathological features for the two species (30).
Peroxisomal fatty acid oxidation disorders have also been described in humans (reviewed in 28, [3H]oleic acid was injected I.P. and Iivers harvested after a 15 min pulse. Lipids were extracted and separated by thin layer chromatography on silica plates (see Methods and 
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Database and correspond to the numbers indicated in Table 2 . The gel is oriented with acidic proteins to the left, basic proteins to the right, high molecular weight proteins toward the top, and low molecular weight proteins toward the bottom. All proteins indicated with arrows exhibited elevated levels in fldfld compared to wild-type mice, except spots 36 and 112, which were diminished in fld/fld liver. Relative levels of all indicated proteins are given in Table 2 . Integrated densities and characteristics of proteins with altered expression levels in neonatal fldfld liver. Protein densities were determined for liver samples from each of 10 wild-typpe (wt) and 10 fld/fld mice; numbers in parentheses represent the coefficient of variation for determinations of 10 animals of each phenotype. The 25 proteins listed were significantly different in the fld/fld livers (pcO.001). Molecular weight and peroxisome proliferator response data are from the mouse protein database (13). n.d., not determined.
